Publications

Robert M. Grant, MD, MPHJain V, Liegler T, Vittinghoff E, Hartogensis W, Bacchetti P, Poole L, Loeb L, Pilcher CD, Grant RM, Deeks SG, Hecht FM. Transmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. PLoS One. 2010; 5(12):e15510. View in: PubMed
Robert Grant, MD, MPHBone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. View in: PubMed
Robert M. Grant, MD, MPHAnderson PL, Kiser JJ, Gardner EM, Rower JE, Meditz A, Grant RM. Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. J Antimicrob Chemother. 2011 Feb; 66(2):240-50. View in: PubMed
Robert Grant, MD, MPHDifferential persistence of transmitted HIV-1 drug resistance mutation classes. View in: PubMed
Robert M. Grant, MD, MPHGrant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, Goicochea P, Casapía M, Guanira-Carranza JV, Ramirez-Cardich ME, Montoya-Herrera O, Fernández T, Veloso VG, Buchbinder SP, Chariyalertsak S, Schechter M, Bekker LG, Mayer KH, Kallás EG, Amico KR, Mulligan K, Bushman LR, Hance RJ, Ganoza C, Defechereux P, Postle B, Wang F, McConnell JJ, Zheng JH, Lee J, Rooney JF, Jaffe HS, Martinez AI, Burns DN, Glidden DV. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30; 363(27):2587-99. View in: PubMed
Robert Grant, MD, MPHTransmitted drug resistance in persons with acute/early HIV-1 in San Francisco, 2002-2009. View in: PubMed
Robert M. Grant, MD, MPHBurrell E, Mark D, Grant R, Wood R, Bekker LG. Sexual risk behaviours and HIV-1 prevalence among urban men who have sex with men in Cape Town, South Africa. Sex Health. 2010 Jun; 7(2):149-53. View in: PubMed
Robert Grant, MD, MPHPharmacological considerations for tenofovir and emtricitabine to prevent HIV infection. View in: PubMed
Robert Grant, MD, MPHPreexposure chemoprophylaxis for HIV prevention in men who have sex with men. View in: PubMed
Robert M. Grant, MD, MPHGrant RM. Antiretroviral agents used by HIV-uninfected persons for prevention: pre- and postexposure prophylaxis. Clin Infect Dis. 2010 May 15; 50 Suppl 3:S96-101. View in: PubMed